ALT profile · all as-reported value updates
Altimmune, Inc. (ALT) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2016 | 193,854,173 | -11,086,812 | -204,940,985 | -105.72% | revised comparative figure | 0001144204-17-014528 0001193125-18-103623 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2016 | 153,994,922 | 2,876,113 | -151,118,809 | -98.13% | revised comparative figure | 0001144204-17-014528 0001193125-18-103623 | 2 filed observations examined for this concept and period. |
| Liabilities | 2016 | 205,280,132 | 6,193,012 | -199,087,120 | -96.98% | revised comparative figure | 0001144204-17-014528 0001193125-18-103623 | 2 filed observations examined for this concept and period. |
| Assets | 2016 | 224,739,223 | 38,400,335 | -186,338,888 | -82.91% | revised comparative figure | 0001144204-17-014528 0001193125-18-103623 | 2 filed observations examined for this concept and period. |
| Stockholders' equity | 2016 | 19,459,091 | 32,207,323 | 12,748,232 | +39.58% | revised comparative figure | 0001144204-17-014528 0001564590-19-010429 | 3 filed observations examined for this concept and period. |